The MHRA has approved depemokimab as an add on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

Monthly injection with tezepelumab helped 90% of patients with severe asthma reduce intake of daily steroid tablets. The ...

Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is ...

UK's health regulator on Monday approved GSK's twice-yearly drug for use as an add-on treatment for asthma in patients aged 12 and older, as well as for a chronic inflammatory sinus condition in ...

Monthly monoclonal antibody injection tezepelumab is so effective in patients with severe asthma, half are able to stop daily ...

They found that an injected antibody called tezepelumab allowed 90% of people with severe asthma to reduce their use of daily ...

A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid ...

Daily steroid pills are often necessary for severe cases of asthma, but they raise the risk of several serious conditions. Now, scientists have shown that a monthly antibody injection can eliminate th ...

Monthly Injection Could Free People With Severe Asthma From Steroids By Ernie Mundell HealthDay ReporterMONDAY, Dec. 1, 2025 (HealthDay News) — People with severe asthma often take daily steroid ...